Biopharmaceutical Fermentation System Market: Trends, Forecast and Competitive Analysis

The Impact of COVID-19 is included in Biopharmaceutical Fermentation System Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry

The future of the biopharmaceutical fermentation system market looks promising with opportunities in applications, such as recombinant proteins, monoclonal antibodies, antibiotics, and probiotics. The global biopharmaceutical fermentation system market is expected to grow with a CAGR of 6%-8% from 2020 to 2025. The major drivers for this market are increasing the demand for biotech based drugs and rising research and development activities to produce novel biological drugs.

A total of XX figures / charts and XX tables are provided in this more than 150 page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global biopharmaceutical fermentation system market report, please download the report brochure.

Biopharmaceutical Fermentation System Market by Product, End Use and Application

In this market, downstream products is the largest product segment of biopharmaceutical fermentation system, whereas development of recombinant proteins is the largest application. Growth in various segments of the biopharmaceutical fermentation system market are given below:

Biopharmaceutical Fermentation System Market by Segments

The study includes trends and forecast for the global biopharmaceutical fermentation system market by product, application, end use, and region as follows:

By Product [Value ($ Million) shipment analysis for 2014 – 2025]:

Upstream Products
Fermenters
Bioprocess Analyzers
Process Monitoring Devices
Culture and Media Preparation
Culture Media
Buffers and Inducers
Other Upstream Products
Downstream Products
Filtration and Separation Systems
Chromatography
Consumables and Accessories
Other Downstream Products

By Application [Value ($ Million) shipment analysis for 2014 – 2025]:

Recombinant Proteins
Monoclonal Antibodies
Antibiotics
Probiotics

By End Use [Value ($ Million) shipment analysis for 2014 – 2025]:

Biopharmaceutical Companies
Contract Manufacturing Organizations
Contract Research Organizations
Academic Research Institutes
Food Industry

By Region [Value ($ Million) shipment analysis for 2014 – 2025]:

North America
United States
Canada
Mexico
Europe
United Kingdom
Spain
Germany
France
Asia Pacific
China
India
Japan
The Rest of the World
Brazil

Some of the biopharmaceutical fermentation system companies profiled in this report include GE Healthcare, Thermo Fisher Scientific, Danaher Corporation, Sartorius StedimBiotech, Merck, Eppendorf, Roche, Nova Biomedicals, Lonza, Becton Dickinson and Company, and GEA.

Within this market, recombinant proteins will remain the largest application segment over the forecast period due to high reliance on microbial system for recombinant protein production, increased investment in research activities and the introduction of new protein, and development of recombinant therapeutic antibodies and proteins.

North America will remain the largest region over the forecast period due to well established healthcare infrastructure, presence of key players, and rising industrialization in the region.

Features of the Global Biopharmaceutical Fermentation System Market

Market Size Estimates: Global biopharmaceutical fermentation system market size estimation in terms of value ($M) shipment.
Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
Segmentation Analysis: Global biopharmaceutical fermentation system market size by various segments, such as product, application, end use in terms of value.
Regional Analysis: Global biopharmaceutical fermentation system market breakdown by the North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product, application, end use, and region for the global biopharmaceutical fermentation system market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global biopharmaceutical fermentation system market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

This report answers following key questions

Q.1 What are some of the most promising potential, high-growth opportunities for the global biopharmaceutical fermentation system market by product (upstream products [fermenters, bioprocess analyzers, process monitoring devices, culture and media preparation, culture media, buffers and inducers, and other upstream products] and downstream products [filtration and separation systems, chromatography, consumables and accessories, and other downstream products]), application (recombinant proteins, monoclonal antibodies, antibiotics, and probiotics), end use (biopharmaceutical companies, contract manufacturing organizations, contract research organizations, academic research institutes, and food industry), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global biopharmaceutical fermentation system market?
Q.5 What are the business risks and threats to the global biopharmaceutical fermentation system market?
Q.6 What are the emerging trends in this biopharmaceutical fermentation system market and the reasons behind them?
Q.7 What are some changing demands of customers in this biopharmaceutical fermentation system market?
Q.8 What are the new developments in this biopharmaceutical fermentation system market? Which companies are leading these developments?
Q.9 Who are the major players in this biopharmaceutical fermentation system market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this biopharmaceutical fermentation system market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global biopharmaceutical fermentation system market?

Report Scope

Key Features	Description
Base Year for Estimation	2019
Trend Period (Actual Estimates)	2014-2019
Forecast Period	2020-2025
Pages	More than 150
Market Representation / Units	Revenue in US $ Million
Report Coverage	Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments	Product (Upstream Products (Fermenters, Bioprocess Analyzers, Process Monitoring Devices, Culture and Media Preparation, Culture Media, Buffers and Inducers, and Other Upstream Products) and Downstream Products (Filtration and Separation Systems, Chromatography, Consumables and Accessories, and Other Downstream Products)), Application (Recombinant Proteins, Monoclonal Antibodies, Antibiotics, and Probiotics), and End Use (Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, and Food Industry)
Regional Scope	North America (USA, Mexico, and Canada), Europe (United Kingodm, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization	10% Customization without Any Additional Cost

Ask an Expert

Table of Contents

1. Executive Summary

2. Market Background and Classifications

2.1: Introduction, Background, and Classifications

2.2: Supply Chain

2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2014 to 2025

3.1: Macroeconomic Trends and Forecast

3.2: Global Biopharmaceutical Fermentation System Market Trends and Forecast

3.3: Global Biopharmaceutical Fermentation System Market by Product

3.3.1: Upstream Products

3.3.1.1: Fermenters

3.3.1.2: Bioprocess Analyzers

3.3.1.3: Process Monitoring Devices

3.3.1.4: Culture and Media Preparation

3.3.1.5: Culture Media

3.3.1.6: Buffers and Inducers

3.3.1.7: Other Upstream Products

3.3.2: Downstream Products

3.3.2.1: Filtration and Separation Systems

3.3.2.2: Chromatography

3.3.2.3: Consumables and Accessories

3.3.2.4: Other Downstream Products

3.4: Global Biopharmaceutical Fermentation System Market by Application

3.4.1: Recombinant Proteins

3.4.2: Monoclonal Antibodies

3.4.3: Antibiotics

3.4.4: Probiotics

3.5: Global Biopharmaceutical Fermentation System Market by End Use

3.5.1: Biopharmaceutical Companies

3.5.2: Contract Manufacturing Organizations

3.5.3: Contract Research Organizations

3.5.4: Academic Research Institutes

3.5.5: Food Industry

4. Market Trends and Forecast Analysis by Region

4.1: Global Biopharmaceutical Fermentation System Market by Region

4.2: North American Biopharmaceutical Fermentation System Market

4.2.1: Market by Product: Upstream Products (Fermenters, Bioprocess Analyzers, Process Monitoring Devices, Culture and Media Preparation, Culture Media, Buffers and Inducers, and Other Upstream Products) and Downstream Products (Filtration and Separation Systems, Chromatography, Consumables and Accessories, and Other Downstream Products)

4.2.2: Market by Application: Recombinant Proteins, Monoclonal Antibodies, Antibiotics, and Probiotics

4.2.3: Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, and Food Industry

4.2.4: The United States Biopharmaceutical Fermentation System Market

4.2.5: The Canadian Biopharmaceutical Fermentation System Market

4.2.6: The Mexican Biopharmaceutical Fermentation System Market

4.3: European Biopharmaceutical Fermentation System Market

4.3.1: Market by Product: Upstream Products (Fermenters, Bioprocess Analyzers, Process Monitoring Devices, Culture and Media Preparation, Culture Media, Buffers and Inducers, and Other Upstream Products) and Downstream Products (Filtration and Separation Systems, Chromatography, Consumables and Accessories, and Other Downstream Products)

4.3.2: Market by Application: Recombinant Proteins, Monoclonal Antibodies, Antibiotics, and Probiotics

4.3.3: Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, and Food Industry

4.3.4: The United Kingdom Biopharmaceutical Fermentation System Market

4.3.5: The Spanish Biopharmaceutical Fermentation System Market

4.3.6: The German Biopharmaceutical Fermentation System Market

4.3.7: The French Biopharmaceutical Fermentation System Market

4.4: APAC Biopharmaceutical Fermentation System Market

4.4.1: Market by Product: Upstream Products (Fermenters, Bioprocess Analyzers, Process Monitoring Devices, Culture and Media Preparation, Culture Media, Buffers and Inducers, and Other Upstream Products) and Downstream Products (Filtration and Separation Systems, Chromatography, Consumables and Accessories, and Other Downstream Products)

4.4.2: Market by Application: Recombinant Proteins, Monoclonal Antibodies, Antibiotics, and Probiotics

4.4.3: Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, and Food Industry

4.4.4: The Chinese Biopharmaceutical Fermentation System Market

4.4.5: The Indian Biopharmaceutical Fermentation System Market

4.4.6: The Japanese Biopharmaceutical Fermentation System Market

4.5: ROW Biopharmaceutical Fermentation System Market

4.5.1: Market by Product: Upstream Products (Fermenters, Bioprocess Analyzers, Process Monitoring Devices, Culture and Media Preparation, Culture Media, Buffers and Inducers, and Other Upstream Products) and Downstream Products (Filtration and Separation Systems, Chromatography, Consumables and Accessories, and Other Downstream Products)

4.5.2: Market by Application: Recombinant Proteins, Monoclonal Antibodies, Antibiotics, and Probiotics

4.5.3: Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, and Food Industry

4.5.4: Brazilian Biopharmaceutical Fermentation System Market

5. Competitor Analysis

5.1: Market Share Analysis

5.2: Product Portfolio Analysis

5.3: Operational Integration

5.4: Geographical Reach

5.5: Porter’s Five Forces Analysis

6. Cost Structure Analysis

6.1: Cost of Goods Sold

6.2: SG&A

6.3: EBITDA Margin

7. Growth Opportunities and Strategic Analysis

7.1: Growth Opportunity Analysis

7.1.1: Growth Opportunities for the Global Biopharmaceutical Fermentation System Market by Product

7.1.2: Growth Opportunities for the Global Biopharmaceutical Fermentation System Market by Application

7.1.3: Growth Opportunities for the Global Biopharmaceutical Fermentation System Market by End Use

7.1.4: Growth Opportunities for the Global Biopharmaceutical Fermentation System Market by Region

7.2: Emerging Trends in the Global Biopharmaceutical Fermentation System Market

7.3: Strategic Analysis

7.3.1: New Product Development

7.3.2: Capacity Expansion of the Global Biopharmaceutical Fermentation System Market

7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biopharmaceutical Fermentation System Market

7.3.4: Certification and Licensing

8. Company Profiles of Leading Players

8.1: GE Healthcare

8.2: Thermo Fisher Scientific

8.3: Danaher Corporation

8.4: Sartorius StedimBiotech

8.5: Merck

8.6: Eppendorf

8.7: Roche

8.8: Nova Biomedicals

8.9: Lonza

8.10: Becton Dickinson and Company

Buy full report or by chapter as follows

Price by License Type:

1 User $4,850 2 Users $5,800 5 Users $6,700 Corporate License $8,850

[-] Hide Chapter Details

Title/Chapter Name	Pages	Price

Full Report: Biopharmaceutical Fermentation System Market: Trends, Forecast and Competitive Analysis

Full Report

$ 4,850

150 - page report

Lucintel has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:

In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.

Below is a brief summary of the primary interviews that were conducted by job function for this report.

Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.

Biopharmaceutical Fermentation System Market: Trends, Forecast and Competitive Analysis

Download Sample of This Report

Biopharmaceutical Fermentation System Market: Trends, Forecast and Competitive Analysis